Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

TTelomir Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
T

Telomir Pharmaceuticals, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
May 21, 2026Del Giudice Matthew PaulDirector25,000Incentive Stock Options (right to buy)—Other
May 21, 2026Del Giudice Matthew PaulDirector25,000Incentive Stock Options (right to buy)—Grant / award
May 21, 2026MacPherson Edward CloustonDirector25,000Incentive Stock Options (right to buy)—Other
May 21, 2026MacPherson Edward CloustonDirector25,000Incentive Stock Options (right to buy)—Grant / award
May 21, 2026Whalen Matthew PrattDirector25,000Incentive Stock Options (right to buy)—Other
May 21, 2026Whalen Matthew PrattDirector25,000Incentive Stock Options (right to buy)—Grant / award
May 21, 2026Aminov ErezCEO and Chairman2,000,000Non-Qualified Stock Options (right to buy)—Other
May 21, 2026Aminov ErezCEO and Chairman2,000,000Non-Qualified Stock Options (right to buy)—Grant / award
May 21, 2026Aminov ErezCEO and Chairman1,960,170Incentive Stock Options (right to buy)—Other
May 21, 2026Aminov ErezCEO and Chairman1,960,170Incentive Stock Options (right to buy)—Grant / award
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions